News & Announcements

Lawrence Schwartz

The Vol-PACT project expansion will further advance cutting-edge technologies in the field of image analysis to help track a patient’s response to cancer therapy.

AMP Study on Parkinsons

The FNIH Biomarkers Consortium has launched a project, under its Neuroscience Steering Committee, with the potential to improve diagnosis and the development of targeted therapies for Alzheimer’s Disease (AD) and Major Depressive Disorder (MDD).

AMP Study on Parkinsons

The AMP PD project will focus on identifying and validating promising biomarkers that may be useful in tracking the progression of Parkinson’s disease and could serve as biological targets for the development of new drugs.

Spotlight

Dr. Maria Freire

Learn more about Dr. Freire in this “Women in Business” Q&A featured in the Huffington Post.

Biomarkers Consortium Workshop

The Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium, in partnership with the Food and Drug Administration’s (FDA) Center for Drug Evaluation and Research, is hosting a public meeting entitled Framework for Defining Evidentiary Criteria: Surrogate Endpoint Qualification Workshop on July 30th and 31st, 2018.

 FNIH Rated #1 Charity

The FNIH is delighted to once again earn the highest, 4-star rating from Charity Navigator.

Front Page: